Files in This Item:


Title: Status of antituberculosis drug resistance in Saudi Arabia 1979-98
Authors: Abu Amero, K.K.
Issue Date: 2002
Language: English
Abstract: All published material on the prevalence of drug-resistant tuberculosis within Saudi Arabia over the period 1979-98 was reviewed. The prevalence of single-drug-resistant tuberculosis ranged from 3.4% to 41% for isoniazid, 0% to 23.4% for rifampicin, 0.7% to 22.7% for streptomycin and 0% to 6.9% for ethambutol. The prevalence of multidrug-resistant tuberculosis [defined by WHO as resist1qance to two or more first-line antituberculosis drugs] ranged from 1.5% to 44% in different regions. No strong conclusions could be drawn owing to variations in the populations studied, geographical origins, site of Mycobacterium tuberculosis isolation [pulmonary or extrapulmonary] and drug sensitivity testing. However, the need to develop a standardized national policy for surveillance of drug-resistant tuberculosis in Saudi Arabia is clear
Description: 664-670
Keywords: Antitubercular Agents
Drug Resistance, Multiple, Bacterial
Epidemiology, Molecular
Microbial Sensitivity Tests
Population Surveillance
Research Design
Residence Characteristics
Subject: Tuberculosis, Multidrug-Resistant
ISSN: 1020-3397
Other Identifiers:
Appears in Collections:EMRO Journal Articles (EMHJ)

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.